Gain Therapeutics, Inc. (GANX)
NASDAQ·Healthcare·Biotechnology
$1.70
-2.31%
Mkt Cap $78.48M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$9.00
Range $8.00 – $10.00
Implied Upside
+429.4%
Consensus $9.00 vs current $1.70
NASDAQ·Healthcare·Biotechnology
$1.70
-2.31%
Mkt Cap $78.48M
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$9.00
Range $8.00 – $10.00
+429.4%
Consensus $9.00 vs current $1.70